Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer

Background and Objectives: Facing neoadjuvant chemotherapy followed by surgery, neoadjuvant immunotherapy is an innovative concept in localized muscle-invasive bladder cancer. Herein, we performed a review of the available and ongoing evidence supporting immune checkpoint inhibitor (ICI) administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyrottes, Arthur, Ouzaid, Idir, Califano, Gianluigi, Hermieu, Jean-Francois, Xylinas, Evanguelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398505/
https://www.ncbi.nlm.nih.gov/pubmed/34440975
http://dx.doi.org/10.3390/medicina57080769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398505/
https://www.ncbi.nlm.nih.gov/pubmed/34440975
http://dx.doi.org/10.3390/medicina57080769

Ejemplares similares